Insulin resistance modulates iron-related proteins in adipose tissue

Diabetes Care

Volumn 37, Issue 4, 2014, Pages 1092-1100

  Moreno Navarrete, José María ^a   Novelle, Marta G ^b   Catalán, Victoria ^c   Ortega, Francisco ^a   Moreno, Maria ^a   Gomez Ambrosi, Javier ^c   Xifra, Gemma ^a   Serrano, Marta ^a   Guerra, Ester ^a   Ricart, Wifredo ^a   Frühbeck, Gema ^c   Diéguez, Carlos ^b   Fernández Real, José Manuel ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERRITIN HEAVY POLYPEPTIDE 1; FERRITIN LIGHT POLYPEPTIDE; FERROPORTIN; INSULIN; IRON BINDING PROTEIN; MESSENGER RNA; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FTH1 GENE; FTL GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON METABOLISM; IRON OVERLOAD; MALE; OBESITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SLC40A1 GENE; SUBCUTANEOUS FAT; TF GENE; TFRC GENE; WEIGHT REDUCTION; METABOLISM; MIDDLE AGED;

ADULT; BARIATRIC SURGERY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; IRON-BINDING PROTEINS; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; SUBCUTANEOUS FAT; WEIGHT LOSS;

EID: 84897861600     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1602     Document Type: Article

References (44)

1. Salonen JT, Tuomainen T-P, Nyyssönen K, Lakka H-M, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 1998;317:727-730
2. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422-2428 (Pubitemid 39281396)
3. Fernández-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998;21:62-68 (Pubitemid 28030387)
4. Haap M, Fritsche A, Mensing HJ, Häring HU, Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med 2003;139:869-871
5. Fernández-Real JM, López-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem 2005;51:1201-1205 (Pubitemid 43079398)
6. Dekker LH, Nicolaou M, van der A DL, et al. Sex differences in the association between serum ferritin and fasting glucose in type 2 diabetes among South Asian Surinamese, African Surinamese, and ethnic Dutch: the population-based SUNSET study. Diabetes Care 2013;36:965-971
7. Lao TT, Tam K-F. Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 1997;20:1368-1369 (Pubitemid 27366809)
8. Lao TTCP, Chan PL, Tam KF. Gestational diabetes mellitus in the last trimester - a feature of maternal iron excess? Diabet Med 2001;18:218-223 (Pubitemid 32397860)
9. Dandona P, Hussain MA, Varghese Z, Politis D, Flynn DM, Hoffbrand AV. Insulin resistance and iron overload. Ann Clin Biochem 1983;20:77-79 (Pubitemid 13097569)
10. Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986;261:8708-8711 (Pubitemid 17205066)
11. Facchini FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 1998;21:2190 (Pubitemid 28549172)
12. Hua NW, Stoohs RA, Facchini FS. Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 2001;86:515-519 (Pubitemid 32982200)
13. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-57 (Pubitemid 32050435)
14. Bofill C, Joven J, Bages J, et al. Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism 1994;43:614-620 (Pubitemid 24145469)
15. Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and β-cell function. Diabetes 2002;51:1000-1004 (Pubitemid 34438342)
16. Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care 2007;30:1926-1933 (Pubitemid 47036384)
17. Rajpathak SN, Crandall JP, Wylie-Rosett J, et al. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 2009;1790:671-681
18. Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med 2012;10:119
19. Zhao Z, Li S, Liu G, et al. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis. PLoS ONE 2012;7:e41641
20. Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Res Rev 2013;29:308-318
21. Iwasaki T, Nakajima A, Yoneda M, et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005;28:2486-2491 (Pubitemid 41384298)
22. Wlazlo N, van Greevenbroek MM, Ferreira I, et al. Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Diabetes Care 2013;36:309-315
23. Gabrielsen JS, Gao Y, Simcox JA, et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 2012;122:3529-3540
24. Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, Colonna A. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes. J Biol Chem 2000;275:36708-36712 (Pubitemid 32002076)
25. Farahani P, Chiu S, Bowlus CL, et al. Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin. Obes Res 2004;12:191-204 (Pubitemid 41132542)
26. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011;434:365-381
27. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009;122:78-86
28. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788-796 (Pubitemid 44316823)
29. Moreno-Navarrete JM, Escoté X, Ortega F, et al. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 2013;56:2524-2537
30. Moreno-Navarrete JM, Petrov P, Serrano M, et al. Decreased RB1 mRNA, protein, and activity reflect obesity-induced altered adipogenic capacity in human adipose tissue. Diabetes 2013;62:1923-1931
31. Tajima S, Ikeda Y, Sawada K, et al. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 2012;302:E77-E86
32. Wing RR, Marcus MD, Epstein LH, Salata R. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987;10:563-566 (Pubitemid 17158925)
33. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 1986;35:990-998 (Pubitemid 16029818)
34. Dongiovanni P, Ruscica M, Rametta R, et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol 2013;182:2254-2263
35. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011;121:2094-2101
36. Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS ONE 2011;6:e18284
37. Kim JY, van de Wall E, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621-2637 (Pubitemid 47494363)
38. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta 2010;1801:338-349
39. Bourlier V, Zakaroff-Girard A, Miranville A, et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008;117:806-815 (Pubitemid 351640682)
40. Ortega FJ, Mayas D, Moreno-Navarrete JM, et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 2010;18:13-20
41. Lesnefsky EJ. Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Adv Exp Med Biol 1994;366:129-146
42. Tinkov AA, Polyakova VS, Nikonorov AA. Chronic administration of iron and copper potentiates adipogenic effect of high fat diet in Wistar rats. Biometals 2013;26:447-463
43. Zheng X, Jiang T, Wu H, et al. Hepatic iron stores are increased as assessed by magnetic resonance imaging in a Chinese population with altered glucose homeostasis. Am J Clin Nutr 2011;94:1012-1019
44. Haap M, Machann J, von Friedeburg C, et al. Insulin sensitivity and liver fat: role of iron load. J Clin Endocrinol Metab 2011;96:E958-E961